Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?

Authors
Type
Published Article
Journal
Critical reviews in toxicology
Publication Date
Volume
42
Issue
2
Pages
91–106
Identifiers
DOI: 10.3109/10408444.2011.623151
PMID: 22141324
Source
Medline
License
Unknown

Abstract

The 2-year rodent carcinogenicity bioassay evolved more than 40 years ago, and although it is complex, long lasting, expensive, and animal consuming, it is still the only generally accepted test for assessing the carcinogenicity of chemicals. Over time, different alternative approaches have been developed with the final goal to replace the bioassay. Unfortunately, at present, none of these strategies alone provides sufficient assurance of accurate prediction. In this review paper, we discuss the major advantages and pitfalls of the existing alternative methodologies to the carcinogenicity bioassay. Finally, based on the available scientific data in the public domain, we propose what we would like to call a "feasible integrated testing strategy" which incorporates some promising alternatives, providing at the same time information on the mechanism of action and the toxic nature of the compounds tested. It is, however, clear that the adoption of whatever "new" testing scheme should be considered with caution and its effectiveness should be experimentally demonstrated in advance by addressing a reasonable number of chemical carcinogens and non-carcinogens from a variety of structural and functional classes.

Statistics

Seen <100 times